InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,095.60
(
2.05%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.59
(
0.02%
)
Bitcoin
66,761.43
(
0.53%
)
Post# of 660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

smallbio

Send PM Follow Ignore
Followers 1
Posts 191
Boards Moderated 0
Alias Born 05/09/2012

smallbio

Re: BillyBahama post# 217

Monday, 05/06/2019 11:25:37 AM

Monday, May 06, 2019 11:25:37 AM

Post# of 660
The move from 1Q20 to 2H19 is the MOMENTUM trial of AXS-07 for migraine.

The move from 2Q19 to 2H19 STRIDE-1 trial is of AXS-05 for TRD.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AXSM News
More AXSM News
InvestorsHub NewsWire

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM

Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!